These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6869235)

  • 21. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
    Mirro MJ; Webel RR; Kelly KJ; Grina LA
    J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate.
    Goldberger AL; Pavelec RS
    Int J Cardiol; 1986 Oct; 13(1):47-55. PubMed ID: 3771001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of ventricular arrhythmias: evaluation of standard therapy and recent advances.
    Vismara LA; Miller RR; DeMaria AN; Amsterdam EA; Vera Z; Mason DT
    Heart Lung; 1976; 5(3):485-92. PubMed ID: 4417
    [No Abstract]   [Full Text] [Related]  

  • 24. Bretylium, a Class III Antiarrhythmic, Returns to the Market.
    Thind M; Sullivan RM; Williams RN; Kowey PR
    Am J Cardiol; 2020 Oct; 133():77-80. PubMed ID: 32843146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of bretylium tosylate on ventricular function.
    Saunders WH; Behar VS
    Am J Med Sci; 1973 Apr; 265(4):287-95. PubMed ID: 4540979
    [No Abstract]   [Full Text] [Related]  

  • 27. Electrophysiologic properties of antidysrhythmic drugs as a rational basis for therapy.
    Arnsdorf MF
    Med Clin North Am; 1976 Mar; 60(2):213-32. PubMed ID: 1256112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newer antiarrhythmic drugs.
    Dhurandhar RW; Bhansali SK
    J La State Med Soc; 1979 Apr; 131(4):102-8. PubMed ID: 379253
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.
    Bacaner M
    Int J Cardiol; 1983 Sep; 4(2):133-52. PubMed ID: 6354941
    [No Abstract]   [Full Text] [Related]  

  • 30. Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.
    Duff HJ; Roden DM; Yacobi A; Robertson D; Wang T; Maffucci RJ; Oates JA; Woosley RL
    Am J Cardiol; 1985 Feb; 55(4):395-401. PubMed ID: 3969876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The experimental basis for the choice of an anti-arrhythmic drug.
    Vaughan Williams EM
    Adv Cardiol; 1970; 4():275-89. PubMed ID: 4395423
    [No Abstract]   [Full Text] [Related]  

  • 32. Bretylium tosylate--induced stabilization of electrical systole duration in patients with acute myocardial infarction.
    Jouve R; Puddu PE; Torresani J
    Heart Lung; 1982; 11(5):399-405. PubMed ID: 6921188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinidine syncope. A report of successful treatment with bretylium tosylate.
    VanderArk CR; Reynolds EW; Kahn DR; Tullett G
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):464-7. PubMed ID: 957762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation.
    Lathers CM; Gerard-Ciminera JL; Baskin SI; Krusz JC; Kelliher GJ; Goldberg PB; Roberts J
    J Cardiovasc Pharmacol; 1982; 4(1):91-8. PubMed ID: 6176806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of bretylium tosylat on the human atrio-ventricular and intraventricular conduction].
    Abate G; Zacà F; Polimeni RM; Alberici S
    Boll Soc Ital Cardiol; 1976; 21(4):601-8. PubMed ID: 1031024
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bretylium tosylate, a new original anti-arrhythmic agent].
    Warembourg H; Vermeersch M; Pauchant M; Ducloux G; Delebecque H
    Lille Med; 1972 Feb; 17(2):201-4. PubMed ID: 5038050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.